Stock listing
Synmosa Biopharma Corp
Selected listing: 4114 · TPEX · TWD · TW
Synmosa Biopharma Corp (TPEx:4114), Health Technology. Latest release Aug 11, 2022: Synmosa Biopharma : To announces SYNMOSA board of directors has lifted…
- Ticker
- TPEx:4114
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TPEx
- Currency
- TWD
About Synmosa Biopharma Corp
Synmosa Biopharma Corp is a publicly traded company on the Taiwan stock market under the ticker 4114. Synmosa focuses on the biopharmaceutical sector, contributing to advancements in healthcare and medicine.
Latest news from Synmosa Biopharma Corp
Synmosa Biopharma : To announces SYNMOSA board of directors has lifted the restriction on the prohibition of competition for managerial officer
August 11, 2022
Synmosa Biopharma : The Company's 2022 Second quarter consolidated financial statements have been reported to the Board
August 11, 2022
Synmosa Biopharma : Announcement of the Company's adjustment of the number for the transfer treasury shares to employees through the resolution of the board of directors on 7/29
August 2, 2022
Synmosa Biopharma : Announcement of the Company's board of directors resolution on transfer treasury shares to employees and the record date of share subscription
July 29, 2022
Synmosa Biopharma : announces the record date for 2021 dividend through retained earning.
June 22, 2022
Research Synmosa Biopharma Corp
Synmosa Biopharma Corp company profile
View the public company page for Synmosa Biopharma Corp on 6ix.
Synmosa Biopharma Corp news
Read company news and market updates connected to Synmosa Biopharma Corp.
Synmosa Biopharma Corp investor events
Find investor webinars, events, and replay context for Synmosa Biopharma Corp.